After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.
Stocks Info
As a NASDAQ listed company, NVCR falls under the Healthcare sector while operating within the Medical Devices industry segment. The current market capitalization of NovoCure Ltd is $1.51B. A total of 1.44 million shares were traded on the day, compared to an average of 1.74M shares.
In the most recent transaction, Cordova Ashley bought 81,550 shares of NVCR for 12.22 per share on Sep 05 ’25. After the transaction, the Chief Executive Officer now owns 437,569 company shares. In a previous transaction on Jul 29 ’25, Brackmann Christoph bought 20,000 shares at 11.59 per share. NVCR shares that Chief Financial Officer owns now total 141,150.
Among the insiders who sold shares, Stafford Kristin disposed of 999 shares on Jun 03 ’25 at a per-share price of $17.28. This resulted in the Director holding 3,054 shares of NVCR after the transaction. In another insider transaction, LEUNG GABRIEL sold 999 shares at $17.31 per share on Jun 03 ’25. Company shares held by the Director now total 81,229.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, NVCR has a high of $32.06 and a low of $10.70.
As of this writing, NVCR has an earnings estimate of -$0.39 per share for the current quarter. EPS was calculated based on a consensus of 7.0 estimates, with a high estimate of -$0.31 per share and a lower estimate of -$0.5. The company reported an EPS of -$0.61 in the last quarter
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. NVCR’s latest balance sheet shows that the firm has $937.70M in Cash & Short Term Investments as of fiscal 2021. There were $575.21M in debt and $142.60M in liabilities at the time. Its Book Value Per Share was $3.05, while its Total Shareholder’s Equity was $410.49M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for NVCR is Buy with a score of 4.25.
